Vascular Endothelium Changes After Bariatric Surgery

Conditions:		Type 2 Diabetes
Purpose:		Improvement in cardiovascular mortality is related to changes in pathologic autoantibodies and in the number of circulating functional replicative competent endothelial progenitor cells (EPC's) after bariatric surgery.
Study Summary:		Same as above
Criteria:		Inclusion Criteria: - Type 2 Diabetes, Glucose > 200mg/dl, currently be ing treated with oral medications and HGA1c . 6.5, and BMI .35. Exclusion Criteria: - Type 1 Diabetes
NCT ID:		NCT01213940
Primary Contact:		Principal Investigator William O Richards, MD University of South Alabama, Department of Surgery
Backup Contact:		N/A
Location Contact:		Mobile, Alabama 36617 United States William O Richards, MD Phone: 251-471-7993 Email: brichards@usouthal.edu Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		June 19, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.